Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.
Novel role for endogenous mitochondrial formylated peptide-driven formyl peptide receptor 1 signalling in acute respiratory distress syndrome.
复制标题
DOI:
10.1136/thoraxjnl-2017-210030
复制
发表时间:
2017-10
期刊:
影响因子:
10
通讯作者:
Rossi AG
中科院分区:
文献类型:
--
作者:
Dorward DA;Lucas CD;Doherty MK;Chapman GB;Scholefield EJ;Conway Morris A;Felton JM;Kipari T;Humphries DC;Robb CT;Simpson AJ;Whitfield PD;Haslett C;Dhaliwal K;Rossi AG
Acute respiratory distress syndrome (ARDS) is an often fatal neutrophil-dominant lung disease. Although influenced by multiple proinflammatory mediators, identification of suitable therapeutic candidates remains elusive. We aimed to delineate the presence of mitochondrial formylated peptides in ARDS and characterise the functional importance of formyl peptide receptor 1 (FPR1) signalling in sterile lung inflammation. Mitochondrial formylated peptides were identified in bronchoalveolar lavage fluid (BALF) and serum of patients with ARDS by liquid chromatography–tandem mass spectrometry. In vitro, human neutrophils were stimulated with mitochondrial formylated peptides and their effects assessed by flow cytometry and chemotaxis assay. Mouse lung injury was induced by mitochondrial formylated peptides or hydrochloric acid. Bone marrow chimeras determined the contribution of myeloid and parenchymal FPR1 to sterile lung inflammation. Mitochondrial formylated peptides were elevated in BALF and serum from patients with ARDS. These peptides drove neutrophil activation and chemotaxis through FPR1-dependent mechanisms in vitro and in vivo. In mouse lung injury, inflammation was attenuated in Fpr1−/− mice, effects recapitulated by a pharmacological FPR1 antagonist even when administered after the onset of injury. FPR1 expression was present in alveolar epithelium and chimeric mice demonstrated that both myeloid and parenchymal FPR1 contributed to lung inflammation. We provide the first definitive evidence of mitochondrial formylated peptides in human disease and demonstrate them to be elevated in ARDS and important in a mouse model of lung injury. This work reveals mitochondrial formylated peptide FPR1 signalling as a key driver of sterile acute lung injury and a potential therapeutic target in ARDS.
登录
查看更多内容
影响因子:
5.5
作者:
Dorward DA;Lucas CD;Alessandri AL;Marwick JA;Rossi F;Dransfield I;Haslett C;Dhaliwal K;Rossi AG
通讯作者:
Rossi AG
影响因子:
7.4
作者:
Kung CT;Hsiao SY;Tsai TC;Su CM;Chang WN;Huang CR;Wang HC;Lin WC;Chang HW;Lin YJ;Cheng BC;Su BY;Tsai NW;Lu CH
通讯作者:
Lu CH
DOI:
10.1164/rccm.200812-1928oc
发表时间:
2009-07-01
影响因子:
24.7
作者:
Conway Morris A;Kefala K;Wilkinson TS;Dhaliwal K;Farrell L;Walsh T;Mackenzie SJ;Reid H;Davidson DJ;Haslett C;Rossi AG;Sallenave JM;Simpson AJ
通讯作者:
Simpson AJ
影响因子:
5.4
作者:
Rabiet, MJ;Huet, E;Boulay, F
通讯作者:
Boulay, F
DOI:
10.1183/09031936.00093911
发表时间:
2012-05
期刊:
The European respiratory journal
影响因子:
--
作者:
Patel BV;Wilson MR;Takata M
通讯作者:
Takata M